Quadrant Capital Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.99M | Buy |
10,124
+2,482
| +32% | +$737K | 0.09% | 177 |
|
|
2025
Q4 | $2.09M | Buy |
7,642
+24
| +0.3% | +$6.52K | 0.06% | 249 |
|
|
2025
Q3 | $2.06M | Buy |
7,618
+75
| +1% | +$20.4K | 0.07% | 240 |
|
|
2025
Q2 | $2.08M | Buy |
7,543
+297
| +4% | +$80.8K | 0.07% | 217 |
|
|
2025
Q1 | $1.92M | Buy |
7,246
+4,152
| +134% | +$1.02M | 0.07% | 200 |
|
|
2024
Q4 | $719K | Buy |
3,094
+101
| +3% | +$23.2K | 0.05% | 252 |
|
|
2024
Q3 | $660K | Buy |
2,993
+33
| +1% | +$6.83K | 0.05% | 281 |
|
|
2024
Q2 | $582K | Sell |
2,960
-139
| -4% | -$28.7K | 0.04% | 288 |
|
|
2024
Q1 | $667K | Sell |
3,099
-612
| -16% | -$129K | 0.05% | 263 |
|
|
2023
Q4 | $782K | Buy |
3,711
+328
| +10% | +$70K | 0.07% | 211 |
|
|
2023
Q3 | $677K | Buy |
3,383
+195
| +6% | +$38.8K | 0.07% | 209 |
|
|
2023
Q2 | $591K | Sell |
3,188
-256
| -7% | -$47.3K | 0.06% | 227 |
|
|
2023
Q1 | $660K | Buy |
3,444
+901
| +35% | +$163K | 0.07% | 211 |
|
|
2022
Q4 | $428K | Buy |
2,543
+3
| +0.1% | +$521 | 0.05% | 281 |
|
|
2022
Q3 | $450K | Sell |
2,540
-114
| -4% | -$22.5K | 0.06% | 226 |
|
|
2022
Q2 | $543K | Buy |
2,654
+203
| +8% | +$43K | 0.07% | 201 |
|
|
2022
Q1 | $583K | Buy |
2,451
+118
| +5% | +$27.7K | 0.07% | 200 |
|
|
2021
Q4 | $533K | Buy |
2,333
+206
| +10% | +$45.3K | 0.06% | 200 |
|
|
2021
Q3 | $411K | Sell |
2,127
-62
| -3% | -$12.6K | 0.06% | 219 |
|
|
2021
Q2 | $466K | Buy |
2,189
+516
| +31% | +$109K | 0.07% | 198 |
|
|
2021
Q1 | $342K | Buy |
1,673
+398
| +31% | +$78.4K | 0.06% | 234 |
|
|
2020
Q4 | $232K | Sell |
1,275
-301
| -19% | -$51.2K | 0.04% | 269 |
|
|
2020
Q3 | $264K | Buy |
1,576
+187
| +13% | +$31.5K | 0.06% | 209 |
|
|
2020
Q2 | $226K | Sell |
1,389
-1,908
| -58% | -$342K | 0.05% | 243 |
|
|
2020
Q1 | $571K | Buy |
3,297
+755
| +30% | +$150K | 0.1% | 185 |
|
|
2019
Q4 | $486K | Buy |
2,542
+318
| +14% | +$65.2K | 0.06% | 316 |
|
|
2019
Q3 | $452K | Buy |
2,224
+75
| +3% | +$15.7K | 0.07% | 281 |
|
|
2019
Q2 | $403K | Buy |
2,149
+438
| +26% | +$80.7K | 0.06% | 300 |
|
|
2019
Q1 | $267K | Buy |
1,711
+360
| +27% | +$63.6K | 0.05% | 396 |
|
|
2018
Q4 | $239K | Buy |
1,351
+194
| +17% | +$35.8K | 0.06% | 288 |
|
|
2018
Q3 | $184K | Buy |
1,157
+22
| +2% | +$3.7K | 0.05% | 261 |
|
|
2018
Q2 | $174K | Sell |
1,135
-5
| -0.4% | -$817 | 0.06% | 272 |
|
|
2018
Q1 | $168K | Buy |
1,140
+9
| +0.8% | +$1.43K | 0.06% | 279 |
|
|
2017
Q4 | $152K | Buy |
1,131
+16
| +1% | +$2.28K | 0.06% | 288 |
|
|
2017
Q3 | $145K | Buy |
1,115
+171
| +18% | +$21.6K | 0.06% | 288 |
|
|
2017
Q2 | $111K | Buy |
944
+113
| +14% | +$13.5K | 0.05% | 313 |
|
|
2017
Q1 | $92K | Buy |
831
+54
| +7% | +$6.5K | 0.04% | 373 |
|
|
2016
Q4 | $83K | Sell |
777
-10
| -1% | -$1.11K | 0.04% | 303 |
|
|
2016
Q3 | $75K | Buy |
787
+9
| +1% | +$940 | 0.05% | 311 |
|
|
2016
Q2 | $70K | Buy |
778
+100
| +15% | +$9.45K | 0.05% | 310 |
|
|
2016
Q1 | $61K | Sell |
678
-701
| -51% | -$63.8K | 0.04% | 336 |
|
|
2015
Q4 | $120K | Buy |
1,379
+87
| +7% | +$8.19K | 0.08% | 213 |
|
|
2015
Q3 | $117K | Buy |
1,292
+67
| +5% | +$6.37K | 0.08% | 209 |
|
|
2015
Q2 | $112K | Buy |
+1,225
| New | +$114K | 0.07% | 225 |
|
Other funds holding CME
VCM
VPM
Quadrant Capital Group's CME Position: Q1 2026 in Review
Quadrant Capital Group increased its CME Group (CME) stake by 32% in Q1 2026, buying an estimated $737K and bringing the position to 10,124 shares worth $2.99M. The position accounts for 0.09% of the portfolio, ranked #177.
Quadrant Capital Group first reported a position in CME in Q2 2015 and has held it in 44 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Quadrant Capital Group held 10,124 shares of CME Group worth $2.99M as of Q1 2026.
- Quadrant Capital Group bought 2,482 CME Group shares in Q1 2026, an estimated $737K.
- CME Group made up 0.09% of Quadrant Capital Group's portfolio in Q1 2026, its #177 holding.
- Quadrant Capital Group first reported a position in CME Group in Q2 2015 and has held it in 44 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.